XT
LIMN

XTX Topco’s Liminatus Pharma LIMN Stock Holding History

XTX Topco’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Buy
+221,839
New +$38.3K ﹤0.01% 3869

Other funds holding LIMN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Personalized Indexing Management
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco's LIMN Position: Q2 2026 in Review

XTX Topco opened a new position in Liminatus Pharma (LIMN) in Q2 2026: 221,839 shares worth $24.5K. The stake represents ﹤0.01% of the portfolio and ranks #3869 among its holdings.

13 funds tracked by Wall St. Rank hold LIMN as of Q2 2026.

  • XTX Topco held 221,839 shares of Liminatus Pharma worth $24.5K as of Q2 2026.
  • Liminatus Pharma was a new XTX Topco position in Q2 2026.
  • Liminatus Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3869 holding.
  • 13 funds tracked by Wall St. Rank held Liminatus Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.